These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 9182688

  • 1. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.
    Forssmann U, Uguccioni M, Loetscher P, Dahinden CA, Langen H, Thelen M, Baggiolini M.
    J Exp Med; 1997 Jun 16; 185(12):2171-6. PubMed ID: 9182688
    [Abstract] [Full Text] [Related]

  • 2. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
    Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van de Rijn M, Bonventre JV, Oettgen HC, Leder P, Luster AD.
    Mol Med; 1996 May 16; 2(3):334-48. PubMed ID: 8784786
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.
    White JR, Imburgia C, Dul E, Appelbaum E, O'Donnell K, O'Shannessy DJ, Brawner M, Fornwald J, Adamou J, Elshourbagy NA, Kaiser K, Foley JJ, Schmidt DB, Johanson K, Macphee C, Moores K, McNulty D, Scott GF, Schleimer RP, Sarau HM.
    J Leukoc Biol; 1997 Nov 16; 62(5):667-75. PubMed ID: 9365122
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.
    Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, Smith H, Shi X, Gonzalo JA, Newman W, Gutierrez-Ramos JC, Mackay CR.
    J Clin Invest; 1996 Feb 01; 97(3):604-12. PubMed ID: 8609214
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Eotaxin potentiates antigen-dependent basophil IL-4 production.
    Devouassoux G, Metcalfe DD, Prussin C.
    J Immunol; 1999 Sep 01; 163(5):2877-82. PubMed ID: 10453034
    [Abstract] [Full Text] [Related]

  • 9. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
    Sabroe I, Conroy DM, Gerard NP, Li Y, Collins PD, Post TW, Jose PJ, Williams TJ, Gerard CJ, Ponath PD.
    J Immunol; 1998 Dec 01; 161(11):6139-47. PubMed ID: 9834099
    [Abstract] [Full Text] [Related]

  • 10. Eotaxin is a potent chemotaxin for human basophils.
    Yamada H, Hirai K, Miyamasu M, Iikura M, Misaki Y, Shoji S, Takaishi T, Kasahara T, Morita Y, Ito K.
    Biochem Biophys Res Commun; 1997 Feb 13; 231(2):365-8. PubMed ID: 9070280
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells.
    Umland SP, Wan Y, Shortall J, Shah H, Jakway J, Garlisi CG, Tian F, Egan RW, Billah MM.
    J Leukoc Biol; 2000 Mar 13; 67(3):441-7. PubMed ID: 10733106
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
    Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, Ponath PD, Mackay CR.
    J Clin Invest; 1997 Jan 15; 99(2):178-84. PubMed ID: 9005985
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
    Sabroe I, Hartnell A, Jopling LA, Bel S, Ponath PD, Pease JE, Collins PD, Williams TJ.
    J Immunol; 1999 Mar 01; 162(5):2946-55. PubMed ID: 10072545
    [Abstract] [Full Text] [Related]

  • 20. Characterization of chemokine CCR3 agonist-mediated eosinophil recruitment in the Brown-Norway rat.
    Kudlacz EM, Whitney CA, Andresen CJ, Umland JP, Cheng JB.
    Br J Pharmacol; 1999 Oct 01; 128(3):788-94. PubMed ID: 10516663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.